101 related articles for article (PubMed ID: 12120213)
1. Growth factors in pancreatic health and disease.
Balaz P; Friess H; Büchler MW
Pancreatology; 2001; 1(4):343-55. PubMed ID: 12120213
[TBL] [Abstract][Full Text] [Related]
2. Role of growth factors in pancreatic cancer.
Korc M
Surg Oncol Clin N Am; 1998 Jan; 7(1):25-41. PubMed ID: 9443985
[TBL] [Abstract][Full Text] [Related]
3. Growth factors in development and diseases of the exocrine pancreas.
Kiehne K; Otte JM; Fölsch UR; Herzig KH
Pancreatology; 2001; 1(1):15-23. PubMed ID: 12120262
[No Abstract] [Full Text] [Related]
4. Molecular mechanisms in chronic pancreatitis.
Esposito I; Friess H; Büchler MW
Zentralbl Chir; 2001 Nov; 126(11):867-72. PubMed ID: 11753795
[TBL] [Abstract][Full Text] [Related]
5. Chronic pancreatitis: pathogenesis and molecular aspects.
Kleeff J; Friess H; Korc M; Büchler MW
Ann Ital Chir; 2000; 71(1):3-10. PubMed ID: 10829517
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer: factors regulating tumor development, maintenance and metastasis.
Shi X; Friess H; Kleeff J; Ozawa F; Büchler MW
Pancreatology; 2001; 1(5):517-24. PubMed ID: 12120231
[TBL] [Abstract][Full Text] [Related]
7. Molecular prognostic markers in pancreatic cancer.
Ghaneh P; Kawesha A; Evans JD; Neoptolemos JP
J Hepatobiliary Pancreat Surg; 2002; 9(1):1-11. PubMed ID: 12021893
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog signaling in the normal and diseased pancreas.
Kayed H; Kleeff J; Osman T; Keleg S; Büchler MW; Friess H
Pancreas; 2006 Mar; 32(2):119-29. PubMed ID: 16552330
[TBL] [Abstract][Full Text] [Related]
9. Signaling pathways in pancreatic cancer.
Reddy SA
Cancer J; 2001; 7(4):274-86. PubMed ID: 11561604
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer.
Barton CM; Hall PA; Hughes CM; Gullick WJ; Lemoine NR
J Pathol; 1991 Feb; 163(2):111-6. PubMed ID: 1707959
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of FGF-2, PDGF-A, VEGF and TGF beta RII in the pancreas in the course of ischemia/reperfusion-induced acute pancreatitis.
Warzecha Z; Dembiński A; Ceranowicz P; Dembiński M; Kownacki P; Konturek SJ; Tomaszewska R; Stachura J; Hładki W; Pawlik WW
J Physiol Pharmacol; 2004 Dec; 55(4):791-810. PubMed ID: 15613744
[TBL] [Abstract][Full Text] [Related]
12. Growth factors and cancer.
Goustin AS; Leof EB; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease.
Rane SG; Lee JH; Lin HM
Cytokine Growth Factor Rev; 2006; 17(1-2):107-19. PubMed ID: 16257256
[TBL] [Abstract][Full Text] [Related]
14. Has the biology and treatment of pancreatic diseases evolved?
Adler G
Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():83-90. PubMed ID: 15588799
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma.
Beger C; Ramadani M; Meyer S; Leder G; Krüger M; Welte K; Gansauge F; Beger HG
Clin Cancer Res; 2004 Jun; 10(11):3780-7. PubMed ID: 15173085
[TBL] [Abstract][Full Text] [Related]
17. Pancreatitis-associated protein levels in pancreatic juice from patients with pancreatic diseases.
Motoo Y; Watanabe H; Yamaguchi Y; Xie MJ; Mouri H; Ohtsubo K; Okai T; Wakabayashi T; Sawabu N
Pancreatology; 2001; 1(1):43-7. PubMed ID: 12120267
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of heat shock proteins in pancreatic carcinoma.
Gress TM; Müller-Pillasch F; Weber C; Lerch MM; Friess H; Büchler M; Beger HG; Adler G
Cancer Res; 1994 Jan; 54(2):547-51. PubMed ID: 8275493
[TBL] [Abstract][Full Text] [Related]
19. p16(INK4a) alterations in chronic pancreatitis-indicator for high-risk lesions for pancreatic cancer.
Gerdes B; Ramaswamy A; Kersting M; Ernst M; Lang S; Schuermann M; Wild A; Bartsch DK
Surgery; 2001 Apr; 129(4):490-7. PubMed ID: 11283541
[TBL] [Abstract][Full Text] [Related]
20. The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis.
Ceyhan GO; Bergmann F; Kadihasanoglu M; Erkan M; Park W; Hinz U; Giese T; Müller MW; Büchler MW; Giese NA; Friess H
Gut; 2007 Apr; 56(4):534-44. PubMed ID: 17047099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
